| Ruptured aneurysms |
| Number of patients, n |
25 |
25 |
25 |
23 |
21 |
17 |
| Distribution of patients by number of agents, n (%) |
| 0 agents |
21 (84.0%) |
17 (68.0%) |
7 (28.0%) |
14 (60.9%) |
16 (76.2%) |
12 (70.6%) |
| 1 agent |
1 (4.0%) |
3 (12.0%) |
14 (56.0%) |
6 (26.1%) |
2 (9.5%) |
3 (17.6%) |
| 2 agents |
3 (12.0%) |
5 (20.0%) |
4 (16.0%) |
3 (13.0%) |
3 (14.3%) |
2 (11.8%) |
| 3 agents |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| 4 agents |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| Distribution of patients by specific agent, n (%) |
| Aspirin |
4 (16.0%) |
8 (32.0%) |
9 (36.0%) |
9 (39.1%) |
5 (23.8%) |
4 (23.5%) |
| Clopidogrel |
3 (12.0%) |
3 (12.0%) |
2 (8.0%) |
2 (8.7%) |
0 (0.0%) |
0 (0.0%) |
| Cilostazol |
0 (0.0%) |
1 (4.0%) |
10 (40.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| Prasugrel |
0 (0.0%) |
1 (4.0%) |
1 (4.0%) |
1 (4.3%) |
3 (14.3%) |
3 (17.6%) |
| Unruptured aneurysms |
| Number of patients, n |
103 |
103 |
101 |
99 |
97 |
87 |
| Distribution of patients by number of agents, n (%) |
| 0 agents |
3 (2.9%) |
3 (2.9%) |
12 (11.9%) |
19 (19.2%) |
54 (55.7%) |
62 (71.3%) |
| 1 agent |
24 (23.3%) |
25 (24.3%) |
49 (48.5%) |
45 (45.5%) |
29 (29.9%) |
20 (23.0%) |
| 2 agents |
72 (69.9%) |
71 (68.9%) |
39 (38.6%) |
34 (34.3%) |
14 (14.4%) |
5 (5.7%) |
| 3 agents |
4 (3.9%) |
4 (3.9%) |
1 (1.0%) |
1 (1.0%) |
0 (0.0%) |
0 (0.0%) |
| 4 agents |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| Distribution of patients by specific agent, n (%) |
| Aspirin |
96 (93.2%) |
96 (93.2%) |
85 (84.2%) |
75 (75.8%) |
37 (38.1%) |
19 (21.8%) |
| Clopidogrel |
64 (62.1%) |
59 (57.3%) |
31 (30.7%) |
29 (29.3%) |
15 (15.5%) |
6 (6.9%) |
| Cilostazol |
3 (2.9%) |
3 (2.9%) |
2 (2.0%) |
2 (2.0%) |
1 (1.0%) |
2 (2.3%) |
| Prasugrel |
17 (16.5%) |
21 (20.4%) |
12 (11.9%) |
10 (10.1%) |
4 (4.1%) |
3 (3.4%) |
| Total |
| Number of patients, n |
128 |
128 |
126 |
122 |
118 |
104 |
| Distribution of patients by number of agents, n (%) |
| 0 agents |
24 (18.8%) |
20 (15.6%) |
19 (15.1%) |
33 (27.0%) |
70 (59.3%) |
74 (71.2%) |
| 1 agent |
25 (19.5%) |
28 (21.9%) |
63 (50.0%) |
51 (41.8%) |
31 (26.3%) |
23 (22.1%) |
| 2 agents |
75 (58.6%) |
76 (59.4%) |
43 (34.1%) |
37 (30.3%) |
17 (14.4%) |
7 (6.7%) |
| 3 agents |
4 (3.1%) |
4 (3.1%) |
1 (0.8%) |
1 (0.8%) |
0 (0.0%) |
0 (0.0%) |
| 4 agents |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
| Distribution of patients by specific agent, n (%) |
| Aspirin |
100 (78.1%) |
104 (81.3%) |
94 (74.6%) |
84 (68.9%) |
42 (35.6%) |
23 (22.1%) |
| Clopidogrel |
67 (52.3%) |
62 (48.4%) |
33 (26.2%) |
31 (25.4%) |
15 (12.7%) |
6 (5.8%) |
| Cilostazol |
3 (2.3%) |
4 (3.1%) |
12 (9.5%) |
2 (1.6%) |
1 (0.8%) |
2 (1.9%) |
| Prasugrel |
17 (13.3%) |
22 (17.2%) |
13 (10.3%) |
11 (9.0%) |
7 (5.9%) |
6 (5.8%) |
